Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis

Annals of Hepatology

Volumn 11, Issue 6, 2012, Pages 915-920

  Musskopf, Maiara Isabel ^a   Fonseca, Fabricio Pimentel ^a   Gass, Jeferson ^a   de Mattos, Angelo Zambam ^a   John, Jorge Alberto ^a   Brandão, Ajácio Bandeira de Mello ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Cirrhosis; Creatinine; Model for end stage liver disease

Indexed keywords

AMOXICILLIN; BILIRUBIN; CARBAPENEM; CEFOTAXIME; CREATININE; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL PERITONITIS; CLINICAL ARTICLE; DISEASE CLASSIFICATION; FEMALE; HEPATITIS C; HUMAN; INTEGRATED MODEL FOR END STAGE LIVER DISEASE SCORE; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PROGNOSIS; SURVIVAL RATE; UNIVARIATE ANALYSIS;

EID: 84869424592     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31418-8     Document Type: Article

References (26)

1. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epide-miological changes with invasive procedures and norfloxa-cin prophylaxis. Hepatology 2002; 35: 140-8.
2. Coral G, de Mattos AA, Damo DF, Viégas AC. Prevalence and prognosis of spontaneous bacterial peritonitis. Experience in patients from a general hospital in Porto Alegre, RS, Bra-zil (1991-2000). Arq Gastroenterol 2002; 39: 158-62.
3. Nousbaum JB, Cadranel JF, Nahon P, Khac EN, Moreau R, Thevenot T, Silvain C, et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology 2007; 45: 1275-81.
4. Nobre SR, Cabral JE, Gomes JJ, Leitao MC. In-hospital mor-tality in spontaneous bacterial peritonitis: a new predicti-ve model. Eur J Gastroenterol Hepatol 2008; 20: 1176-81.
5. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francito-rra A, Rimola A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical cour-se, predictive factors and prognosis. Hepatology 1994; 20: 1495-501.
6. Soylu AR, Dokmeci G, Tezel A, Umit H, Amuca H, Akova M, Ture M, et al. Predictors of short-term outcome of sponta-neous bacterial peritonitis in Turkish cirrhotic patients. J Gastroenterol Hepatol 2005; 20: 657-60.
7. Terg R, Gadano A, Cartier M, Casciato P, Lucero R, Munoz A, Romero G, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int 2009; 29: 415-9.
8. Cho JH, Park KH, Kim SH, Bang JH, Park WB, Kim HB, Kim NJ, et al. Bacteremia is a prognostic factor for poor out-come in spontaneous bacterial peritonitis. Scand J Infect Dis 2007; 39: 697-702.
9. Bert F, Panhard X, Johnson J, Lecuyer H, Moreau R, Le Grand J, Johnston B, et al. Genetic background of Escheri-chia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis. Clin Microbiol Infect 2008; 14: 1034-40.
10. Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Plo-ner M, Peck-Radosavljevic M, et al. An integrated MELD model including serum sodium and age improves the pre-diction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13: 1174-80.
11. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Ber-nard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32: 142-53.
12. Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outco-mes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150: 19-26.
13. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
14. Lazrak A, Jurkuvenaite A, Chen L, Keeling KM, Collawn JF, Bedwell DM, Matalon S. Enhancement of alveolar epithelial so-dium channel activity with decreased cystic fibrosis trans-membrane conductance regulator expression in mouse lung. Am J Physiol Lung Cell Mol Physiol 2011; 301: L557-67.
15. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
16. Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gas-troenterol Hepatol 2011; 9: 260-5.
17. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Ther-neau TM, Kosberg CL, D'Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepato-logy 2001; 33: 464-70.
19. Said A, Williams J, Holden J, Remington P, Gangnon R, Mus-at A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disea-se. J Hepatol 2004; 40: 897-903.
20. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6.
21. Brandao A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation. Clin Transplant 2008; 22: 651-6.
22. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J He-patol 2011; 54: 1297-306.
23. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systema-tic review of 118 studies. J Hepatol 2006; 44: 217-31.
24. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Li-ver Transpl 2005; 11: 336-43.
25. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients lis-ted for liver transplantation. Hepatology 2005; 41: 32-9.
26. Alves de Mattos A. Current indications for the use of albu-min in the treatment of cirrhosis. Ann Hepatol 2011; 10(Suppl. 1): S15-S20.